New decade of Vaccines

Gary Finnegan

Gary Finnegan

June 15th, 2011

Gary Finnegan

‘The next decade could bring “astonishing success in vaccine biology”, according to experts writing in The Lancet, but this will only be translated into health gains if public trust in vaccines can be regained. ’

New-decade-of-VaccinesLeading medical journal, The Lancet, has published a series of features on the how the next ten years could herald a new wave of advances in immunisation.

‘The New Decade of Vaccines’ includes comment pieces on vaccination, as well as several papers looking at the technological advances driving the latest innovations.

Announcing the publication, the journal described vaccines as “undoubtedly one of the best investments in health”, noting their enormous contribution to reducing the burden of disease and tackling mortality rates worldwide.

The will see molecular biology harnessed to deliver new vaccines and to make manufacturing more efficient. Researchers also have chronic diseases in their sights as they work on ways of protecting an ageing population against Alzheimer’s disease, hypertension and some forms of cancer.

This series from The Lancet follows a and comes as the world’s media descended on London for a major pledging conference hosted by the GAVI Alliance.

The GAVI event has kept vaccines in the headlines for weeks, with high profile political leaders and philanthropists stepping up for a concerted effort to get vaccines to the world’s poorest children.

In parallel to The Lancet series, the Washington-based Health Affairs journal has three posted videos from its recent policy conference on strategies for ‘The Global Decade of Vaccines’.